|
|
Links |
|
Medicines reconciliation standards to be developed by NICE and NPSA |
|
Annual retention fees for pharmacists look set to rise “substantially” next year, according to the Royal Pharmaceutical Society’s President, Hemant Patel. Sir Michael Rawlins, chairman of the National Institute for Health and Clinical Excellence, has told patient groups that they should question the costs of medicines and be wary about donations from pharmaceutical companies. His comments were made at a King’s Fund briefing held last month. A new guideline — “Secondary prevention in primary and secondary care for patients following a myocardial infarction” — has been published by NICE. Feedback on a draft booklet, “Design for safety: labelling and packaging guidelines for injectable medicines” (PDF 1.9MB), is sought by the National Patient Safety Agency. Case studies detailing improvements in services for patients with kidney disease, developed in response to the National Service Framework for Renal Services, are included in the Department of Health’s “Second progress report”. |